Cargando…

The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine

Live attenuated vaccines (LAVs) replicate in the respiratory/oral mucosa, mimic natural infection, and can induce mucosal and systemic immune responses to the full repertoire of SARS-CoV-2 structural/nonstructural proteins. Generally, LAVs produce broader and more durable protection than current COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jiayu, Liu, Mingde, Niu, Xiaoyu, Hanson, Juliette, Jung, Kwonil, Ru, Peng, Tu, Huolin, Jones, Daniel M., Vlasova, Anastasia N., Saif, Linda J., Wang, Qiuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867033/
https://www.ncbi.nlm.nih.gov/pubmed/36680135
http://dx.doi.org/10.3390/v15010095
_version_ 1784876241666441216
author Xu, Jiayu
Liu, Mingde
Niu, Xiaoyu
Hanson, Juliette
Jung, Kwonil
Ru, Peng
Tu, Huolin
Jones, Daniel M.
Vlasova, Anastasia N.
Saif, Linda J.
Wang, Qiuhong
author_facet Xu, Jiayu
Liu, Mingde
Niu, Xiaoyu
Hanson, Juliette
Jung, Kwonil
Ru, Peng
Tu, Huolin
Jones, Daniel M.
Vlasova, Anastasia N.
Saif, Linda J.
Wang, Qiuhong
author_sort Xu, Jiayu
collection PubMed
description Live attenuated vaccines (LAVs) replicate in the respiratory/oral mucosa, mimic natural infection, and can induce mucosal and systemic immune responses to the full repertoire of SARS-CoV-2 structural/nonstructural proteins. Generally, LAVs produce broader and more durable protection than current COVID-19 vaccines. We generated a temperature-sensitive (TS) SARS-CoV-2 mutant TS11 via cold-adaptation of the WA1 strain in Vero E6 cells. TS11 replicated at >4 Log(10)-higher titers at 32 °C than at 39 °C. TS11 has multiple mutations, including those in nsp3, a 12-amino acid-deletion spanning the furin cleavage site of the S protein and a 371-nucleotide-deletion spanning the ORF7b-ORF8 genes. We tested the pathogenicity and protective efficacy of TS11 against challenge with a heterologous virulent SARS-CoV-2 D614G strain 14B in Syrian hamsters. Hamsters were randomly assigned to mock immunization-challenge (Mock-C) and TS11 immunization-challenge (TS11-C) groups. Like the mock group, TS11-vaccinated hamsters did not show any clinical signs and continuously gained body weight. TS11 replicated well in the nasal cavity but poorly in the lungs and caused only mild lesions in the lungs. After challenge, hamsters in the Mock-C group lost weight. In contrast, the animals in the TS11-C group continued gaining weight. The virus titers in the nasal turbinates and lungs of the TS11-C group were significantly lower than those in the Mock-C group, confirming the protective effects of TS11 immunization of hamsters. Histopathological examination demonstrated that animals in the Mock-C group had severe pulmonary lesions and large amounts of viral antigens in the lungs post-challenge; however, the TS11-C group had minimal pathological changes and few viral antigen-positive cells. In summary, the TS11 mutant was attenuated and induced protection against disease after a heterologous SARS-CoV-2 challenge in Syrian hamsters.
format Online
Article
Text
id pubmed-9867033
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98670332023-01-22 The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine Xu, Jiayu Liu, Mingde Niu, Xiaoyu Hanson, Juliette Jung, Kwonil Ru, Peng Tu, Huolin Jones, Daniel M. Vlasova, Anastasia N. Saif, Linda J. Wang, Qiuhong Viruses Article Live attenuated vaccines (LAVs) replicate in the respiratory/oral mucosa, mimic natural infection, and can induce mucosal and systemic immune responses to the full repertoire of SARS-CoV-2 structural/nonstructural proteins. Generally, LAVs produce broader and more durable protection than current COVID-19 vaccines. We generated a temperature-sensitive (TS) SARS-CoV-2 mutant TS11 via cold-adaptation of the WA1 strain in Vero E6 cells. TS11 replicated at >4 Log(10)-higher titers at 32 °C than at 39 °C. TS11 has multiple mutations, including those in nsp3, a 12-amino acid-deletion spanning the furin cleavage site of the S protein and a 371-nucleotide-deletion spanning the ORF7b-ORF8 genes. We tested the pathogenicity and protective efficacy of TS11 against challenge with a heterologous virulent SARS-CoV-2 D614G strain 14B in Syrian hamsters. Hamsters were randomly assigned to mock immunization-challenge (Mock-C) and TS11 immunization-challenge (TS11-C) groups. Like the mock group, TS11-vaccinated hamsters did not show any clinical signs and continuously gained body weight. TS11 replicated well in the nasal cavity but poorly in the lungs and caused only mild lesions in the lungs. After challenge, hamsters in the Mock-C group lost weight. In contrast, the animals in the TS11-C group continued gaining weight. The virus titers in the nasal turbinates and lungs of the TS11-C group were significantly lower than those in the Mock-C group, confirming the protective effects of TS11 immunization of hamsters. Histopathological examination demonstrated that animals in the Mock-C group had severe pulmonary lesions and large amounts of viral antigens in the lungs post-challenge; however, the TS11-C group had minimal pathological changes and few viral antigen-positive cells. In summary, the TS11 mutant was attenuated and induced protection against disease after a heterologous SARS-CoV-2 challenge in Syrian hamsters. MDPI 2022-12-29 /pmc/articles/PMC9867033/ /pubmed/36680135 http://dx.doi.org/10.3390/v15010095 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xu, Jiayu
Liu, Mingde
Niu, Xiaoyu
Hanson, Juliette
Jung, Kwonil
Ru, Peng
Tu, Huolin
Jones, Daniel M.
Vlasova, Anastasia N.
Saif, Linda J.
Wang, Qiuhong
The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine
title The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine
title_full The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine
title_fullStr The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine
title_full_unstemmed The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine
title_short The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine
title_sort cold-adapted, temperature-sensitive sars-cov-2 strain ts11 is attenuated in syrian hamsters and a candidate attenuated vaccine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867033/
https://www.ncbi.nlm.nih.gov/pubmed/36680135
http://dx.doi.org/10.3390/v15010095
work_keys_str_mv AT xujiayu thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT liumingde thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT niuxiaoyu thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT hansonjuliette thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT jungkwonil thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT rupeng thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT tuhuolin thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT jonesdanielm thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT vlasovaanastasian thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT saiflindaj thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT wangqiuhong thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT xujiayu coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT liumingde coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT niuxiaoyu coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT hansonjuliette coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT jungkwonil coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT rupeng coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT tuhuolin coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT jonesdanielm coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT vlasovaanastasian coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT saiflindaj coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine
AT wangqiuhong coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine